Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 4,807,600 | 5,189,600 | 4,586,800 | 4,631,000 | 4,226,100 |
| Cost of Goods | 1,111,300 | 1,272,800 | 1,054,600 | 998,900 | 922,500 |
| Gross Profit | 3,696,300 | 3,916,800 | 3,532,200 | 3,632,100 | 3,303,600 |
| Operating Expenses | 2,514,900 | 2,799,199 | 2,322,900 | 2,708,100 | 2,500,000 |
| Operating Income | 1,181,700 | 1,118,401 | 1,209,900 | 924,900 | 804,100 |
| Other Income | -125,400 | -66,101 | -31,500 | 1,800 | -84,700 |
| Pre-tax Income | 1,056,300 | 1,052,300 | 1,178,400 | 926,700 | 719,400 |
| Income Tax | -8,000 | 197,900 | 252,100 | 263,100 | 210,700 |
| Net Income Continuous | 1,064,300 | 854,400 | 926,300 | 663,600 | 508,700 |
| Net Income | $1,064,300 | $854,400 | $926,300 | $663,600 | $508,700 |
| EPS Basic Total Ops | 0.97 | 0.78 | 0.85 | 0.61 | 0.47 |
| EPS Basic Continuous Ops | 0.98 | 0.78 | 0.85 | 0.61 | 0.47 |
| EPS Diluted Total Ops | 0.97 | 0.78 | 0.85 | 0.61 | 0.47 |
| EPS Diluted Continuous Ops | 0.97 | 0.78 | 0.85 | 0.61 | 0.47 |
| EBITDA(a) | $1,459,200 | $1,393,201 | $1,475,400 | $1,187,400 | $1,049,200 |